000 | 01961 a2200553 4500 | ||
---|---|---|---|
005 | 20250515222709.0 | ||
264 | 0 | _c20100513 | |
008 | 201005s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMoa0910496 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStone, Gregg W | |
245 | 0 | 0 |
_aEverolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cMay 2010 |
||
300 |
_a1663-74 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
650 | 0 | 4 |
_aCoronary Artery Disease _xmortality |
650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
650 | 0 | 4 | _aEverolimus |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 |
_aRetreatment _xstatistics & numerical data |
650 | 0 | 4 | _aSingle-Blind Method |
650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
650 | 0 | 4 |
_aThrombosis _xepidemiology |
650 | 0 | 4 | _aTreatment Failure |
700 | 1 | _aRizvi, Ali | |
700 | 1 | _aNewman, William | |
700 | 1 | _aMastali, Kourosh | |
700 | 1 | _aWang, John C | |
700 | 1 | _aCaputo, Ronald | |
700 | 1 | _aDoostzadeh, Julie | |
700 | 1 | _aCao, Sherry | |
700 | 1 | _aSimonton, Charles A | |
700 | 1 | _aSudhir, Krishnankutty | |
700 | 1 | _aLansky, Alexandra J | |
700 | 1 | _aCutlip, Donald E | |
700 | 1 | _aKereiakes, Dean J | |
773 | 0 |
_tThe New England journal of medicine _gvol. 362 _gno. 18 _gp. 1663-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa0910496 _zAvailable from publisher's website |
999 |
_c19801073 _d19801073 |